The conference is about the key trends that will change the Immune profiling business in the coming years.
Our specific major themes include:
CHARACTERISATION OF THE IMMUNERESPONSE
-
The dual role of biomarkers for understanding basic principles and devising novel intervention strategies in tuberculosis
-
Analysis of the immune system during HIV infection
-
Optimized immune profiling by understanding T-cell and B-cell repertories during cancer
BIOMARKERS AND SURROGATE MARKERS OF VACCINE EFFICACY AND SAFETY
-
Signatures and ink spots of vaccine induced responses
-
Skin immunity for vaccination using omics to better describe the innate immunity and to predict the adaptive immunity
-
Systems integration of innate and adaptive immunity: Implications for vaccine development
IMMUNOSEQUENCING AND HIGH THROUGHPUT ANALYSIS
-
Predictive & Precision medicine: Diagnostic testing, biomarkers and immunoassay systems
-
Rapidly screening a novel affinity scaffold library for PD-L1 Inhibitors
-
Immunosequencing: Combining high-throughput sequencing and bioinformatics to profile T-cell and B-cell receptors
-
Single-cell technologies: Validating discoveries and translating them into clinically useful diagnostic assays
-
Utilising next generation sequencing for fast and accurate processing of sequencing data from T- and B- cell receptor libraries
-
Developing novel antibody immunotherapies that help the immune system attack diseased cells
IMMUNOTHERAPY AND PROFILING IN CANCER
-
Next generation of immune checkpoint inhibitors
-
Identifying solutions to improve the efficacy of PD-1 and CTLA-4
-
Direct identification of neo-epitopes for cancer vaccines and adoptive T-Cell therapies
-
Next generation CAR Technology: Amplifying the immune response within the tumour microenvironment
-
Identifying immunogenic mutations to create immune diagnostics and effective immune monitoring of patients
APPLY TO SPEAK